Search Results

A Phase 3, Randomized, Open-Label, Multicenter, Controlled Study ToEvaluate The Efficacy And Safety Of Zanidatamab In Combination WithPhysician’s Choice Chemotherapy Compared To Trastuzumab InCombination With Physician’s Choice Chemotherapy For The TreatmentOf Participants With Metastatic HER2-Positive Breast Cancer Who HaveProgressed On, Or Are Intolerant To, Previous Trastuzumab DeruxtecanTreatment (EmpowHER 303) MOA: Zanidatamab is a bispecific antibody…

A phase III, open-label, randomised study of Datopotamab Deruxtecan (Dato-DXd) with or without Durvalumab compared with investigator’s choice of chemotherapy (paclitaxel, nab-paclitaxel or gemcitabine + carboplatin) in combination with pembrolizumab in patients with PD-L1 positive locally recurrent inoperable or metastatic Triple-negative Breast Cancer (TROPION-Breast05) MOA: Dato-DXd is a TROP2 targeted ADC with a topoisomerase I…

Child and adult sitting together in front of a decorated Christmas tree. The holidays can be filled with celebrations and time spent with loved ones, but even in the best circumstances, it’s easy to feel overextended and anxious. Finding the balance between self-care and participation can put the focus on good health and cheer while…

[give_receipt]